Search This Blog

Thursday, August 1, 2019

bluebird bio EPS misses by $0.48, beats on revenue

bluebird bio (NASDAQ:BLUE): Q2 GAAP EPS of -$3.55 misses by $0.48.
Revenue of $13.3M (+69.4% Y/Y) beats by $0.17M.
Shares -1.19%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)